Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
The Journal of Biological Chemistry|June 9, 2004
Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipidsKaren Geoffroy, Nicolas Wiernsperger, Michel Lagarde, et al.IUBMB Life|June 28, 2006
Hyperglycemia and glucosamine-induced mesangial cell cycle arrest and hypertrophy: Common or independent mechanisms?Elodie Masson, Michel Lagarde, Nicolas Wiernsperger, et al.Glycobiology|December 31, 2004
Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytesElodie Masson, Nicolas Wiernsperger, Michel Lagarde, et al.The Biochemical Journal|January 19, 2005
Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosidesElodie Masson, Nicolas Wiernsperger, Michel Lagarde, et al.FEBS Letters|February 16, 2005
Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levelsKaren Geoffroy, Lysiane Troncy, Nicolas Wiernsperger, et al.Pharmaceutical Research|October 5, 2023
Preclinical Pharmacokinetics and Translational Pharmacokinetic/Pharmacodynamic Modeling of M8891, a Potent and Reversible Inhibitor of Methionine Aminopeptidase 2Floriane Lignet, Manja Friese-Hamim, Frank Jaehrling, et al.CPT: Pharmacometrics & Systems Pharmacology|November 30, 2021
Using thrombocytopenia modeling to investigate the mechanisms underlying platelet depletion induced by pan-proteasome inhibitorsFloriane Lignet, Andreas D Becker, Claude Gimmi, et al.Diabetes|December 24, 2004
a-Series gangliosides mediate the effects of advanced glycation end products on pericyte and mesangial cell proliferation: a common mediator for retinal and renal microangiopathy?Elodie Masson, Lysiane Troncy, Daniel Ruggiero, et al.CPT: Pharmacometrics & Systems Pharmacology|December 9, 2017
Model-Based Evaluation of Radiation and Radiosensitizing Agents in OncologyTim Cardilin, Joachim Almquist, Mats Jirstrand, et al.Cancer Chemotherapy and Pharmacology|April 13, 2019
Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agentsTim Cardilin, Joachim Almquist, Mats Jirstrand, et al.Pageof 3